ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Says More Phase Trials Needed In Cancer Prevention, Nutrition

April 18, 1986

BMS Award Honors Jordan; Matthews Media Wins $23 Million Contract From MCI.

April 6, 2001

National Cancer Policy Forum Studies Modernization, Funding Of Cooperative Group Program.

July 11, 2008

“Our Job Is to Be The One Agency That Speaks To Cancer”

October 28, 1994

Clearinghouse Says In Business

January 26, 1979

James Doroshow Named NCI Deputy Director, Clinical Research

June 10, 2011